FAAN

Relias Collaborates with American Red Cross To Offer Complimentary Education to Clinicians

Retrieved on: 
Tuesday, April 23, 2024

Relias , the trusted education and workforce enablement partner to 12,000 healthcare and human services organizations, today announced its ongoing collaboration with the American Red Cross .

Key Points: 
  • Relias , the trusted education and workforce enablement partner to 12,000 healthcare and human services organizations, today announced its ongoing collaboration with the American Red Cross .
  • The Red Cross is responding to almost twice as many large disasters as it did a decade ago.
  • This has led to a critical need for more volunteers to support people who depend on the Red Cross for help.
  • “This collaboration with Relias marks our commitment to fostering lifelong learning and health professional development opportunities for both Red Cross employees and volunteers,” said Linda MacIntyre, PhD, RN, PHN, FAAN, Chief Nurse, American Red Cross.

IHI Launches First Collaborative to Accelerate System-Wide Spread of Age-Friendly Care for Older Adults

Retrieved on: 
Tuesday, April 16, 2024

The Institute for Healthcare Improvement (IHI) has launched an Age-Friendly System-Wide Spread Collaborative, engaging 30 US health systems to accelerate and spread adoption of evidence-based, high-quality care for older adults across all of their sites and care settings.

Key Points: 
  • The Institute for Healthcare Improvement (IHI) has launched an Age-Friendly System-Wide Spread Collaborative, engaging 30 US health systems to accelerate and spread adoption of evidence-based, high-quality care for older adults across all of their sites and care settings.
  • The Collaborative is the latest endeavor of the Age-Friendly Health Systems initiative, which has recognized 3,907 care settings as Age-Friendly since 2018, benefiting 3.29 million older adults who have received age-friendly care centered around what matters to them and their families.
  • Age-Friendly Health Systems deliver four evidence-based elements of high-quality care, known as the 4Ms: What Matters, Medication, Mentation, and Mobility.
  • “This is an exciting and ambitious endeavor and responds to the overwhelming interest of systems to deliver age-friendly care to older adults and their family caregivers.

New Research to Examine the Role of Pet Dogs for the Resilience and Wellbeing of Military Adolescents

Retrieved on: 
Wednesday, April 24, 2024

WASHINGTON, April 24, 2024 /PRNewswire-PRWeb/ -- The Human Animal Bond Research Institute (HABRI) today announced a new grant for research that investigates the contribution of pet dog ownership to resilience and well-being in adolescent children of military families. This grant was awarded to a team of researchers at Florida Atlantic University Christine E. Lynn College of Nursing's Canines Providing Assistance to Wounded Warriors (C-P.A.W.W.) led by Laurie Martinez, Ph.D., MBA, MSN, RN, AHN-BC and co-led by Cheryl A. Krause-Parello PhD, RN, FAAN.

Key Points: 
  • Exploring how pet dogs can serve as conduits to better mental health outcomes opens new pathways for daily health promotion.
  • "Exploring how pet dogs can serve as conduits to better mental health outcomes opens new pathways for daily health promotion."
  • This longitudinal, observational pilot study will conduct scientifically-validated surveys to investigate the role of pet dogs in the lives of military adolescents between the ages of 12 to 18.
  • Researchers expect to find higher levels of resilience, improved well-being, reduced depression, and lower perceived stress in dog-owning adolescents compared to military adolescents who do not own a pet dog.

Mitsubishi Tanabe Pharma America to Showcase Breadth of Neurodegenerative Research at 2024 American Academy of Neurology Annual Meeting

Retrieved on: 
Friday, April 12, 2024

JERSEY CITY, N.J., April 12, 2024 /PRNewswire/ -- Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced seven presentations will be shared at the American Academy of Neurology (AAN) 2024 Annual Meeting being held in Denver, Colo., Apr.13-18, 2024.

Key Points: 
  • JERSEY CITY, N.J., April 12, 2024 /PRNewswire/ -- Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced seven presentations will be shared at the American Academy of Neurology (AAN) 2024 Annual Meeting being held in Denver, Colo., Apr.13-18, 2024.
  • The presentations will discuss four abstracts in Parkinson's disease (PD) and three in amyotrophic lateral sclerosis (ALS).
  • Data from the BouNDless subgroup analysis will be presented orally during a Scientific Platform Session at the meeting.
  • ; State University of New York Upstate Medical University)
    Poster Session 6 (#11-013): 8:00 – 9:00 a.m. MDT, April 16

Kyverna Therapeutics to attend the 2024 American Academy of Neurology (AAN) Annual Meeting in Denver, CO, With Data on KYV-101 in the Treatment of Patients with Neurological Autoimmune Diseases

Retrieved on: 
Thursday, April 11, 2024

EMERYVILLE, Calif., April 11, 2024 /PRNewswire/ -- Kyverna Therapeutics, Inc. (Nasdaq: KYTX), a patient-centered, clinical-stage biopharmaceutical company focused on developing cell therapies for patients suffering from autoimmune diseases, announced today its attendance at the 2024 annual meeting of the American Academy of Neurology to be held in Denver, Colorado, starting on April 13.

Key Points: 
  • EMERYVILLE, Calif., April 11, 2024 /PRNewswire/ -- Kyverna Therapeutics, Inc. (Nasdaq: KYTX), a patient-centered, clinical-stage biopharmaceutical company focused on developing cell therapies for patients suffering from autoimmune diseases, announced today its attendance at the 2024 annual meeting of the American Academy of Neurology to be held in Denver, Colorado, starting on April 13.
  • "We look forward to attending AAN and engaging with the scientific community in seeking to develop paradigm-shifting treatment options for patients living with autoimmune diseases," said Peter Maag, Ph.D., chief executive officer of Kyverna.
  • Chimeric antigen receptor (CAR) T-cell therapy involves modifying a patient's T cells to recognize and remove B cells in the patient's body.
  • CD19 CAR T-cell therapy specifically targets CD19, a protein expressed on the surface of B cells, which are involved in various types of autoimmune diseases.

Theravance Biopharma, Inc. to Host Virtual Key Opinion Leader (KOL) Event to Discuss Ampreloxetine's Potential for the Treatment of Symptomatic Neurogenic Orthostatic Hypotension (nOH) in Patients with Multiple System Atrophy (MSA) on May 23, 2024

Retrieved on: 
Wednesday, April 10, 2024

DUBLIN, April 10, 2024 /PRNewswire/ -- Theravance Biopharma, Inc. (the "Company") (NASDAQ: TBPH) today announced it will host a virtual KOL event on Thursday, May 23, 2024 from 10:00 AM to 11:30 AM ET, featuring Horacio Kaufmann, MD, FAAN (Felicia B. Axelrod Professor of Neurology and Professor of Medicine at New York University Grossman School of Medicine) and Italo Biaggioni, MD (Professor of Medicine and Pharmacology Director, Vanderbilt Autonomic Dysfunction Center), who will discuss the unmet need and current treatment landscape for MSA patients with symptomatic nOH.

Key Points: 
  • DUBLIN, April 10, 2024 /PRNewswire/ -- Theravance Biopharma, Inc. (the "Company") (NASDAQ: TBPH) today announced it will host a virtual KOL event on Thursday, May 23, 2024 from 10:00 AM to 11:30 AM ET, featuring Horacio Kaufmann, MD, FAAN (Felicia B. Axelrod Professor of Neurology and Professor of Medicine at New York University Grossman School of Medicine) and Italo Biaggioni, MD (Professor of Medicine and Pharmacology Director, Vanderbilt Autonomic Dysfunction Center), who will discuss the unmet need and current treatment landscape for MSA patients with symptomatic nOH.
  • To register, click here.
  • The event will also feature presentations from the Company's CEO, Rick Winningham, Senior VP of Development, Aine Miller, and Chief Business Officer, Rhonda Farnum and will focus on the Company's clinical development program for ampreloxetine, an investigational, once-daily norepinephrine reuptake inhibitor with the potential to be a first-in-class therapy effective in treating a constellation of cardinal symptoms of nOH in MSA patients.
  • A live question and answer session will follow the formal presentations.

The Health Management Academy Curates an Evening of Excellence for Nursing Executives

Retrieved on: 
Tuesday, April 9, 2024

ARLINGTON, Va., April 9, 2024 /PRNewswire/ -- The Health Management Academy's Nursing Catalyst team will attend the American Organization for Nursing Leadership (AONL) 2024 Annual Conference and meet with Chief Nurse Executives in a specialized setting to discuss the challenges confronting the nursing enterprise. The AONL 2024 Inspiring Leaders Conference, held annually for more than 12,000 organization members, takes place this year in New Orleans, Louisiana, from April 8-11, 2024.

Key Points: 
  • The Nursing Catalyst program, an innovative collaborative comprised of nurse leaders, including Chief Nursing Executives and site Chief Nursing Officers, will bring together Nursing Catalyst members and select invitees during the conference with a shared goal of addressing the biggest challenges to the nursing practice through insight-driven conversation and networking.
  • At the conference, the Nursing Catalyst team will be hosting a reception, offering health system nursing executives the opportunity to benefit from Nursing Catalyst's exclusive research on the variables impacting frontline span-of-control through insights from Vice President, Anne Herleth, and Research Director, Lauren Rewers.
  • It's a rare opportunity to celebrate the hard work and leadership of nursing executives together in one room.
  • Since 1998, The Health Management Academy has cultivated the premier community of healthcare's most influential changemakers from the top U.S. health systems and innovative industry partners.

Dr. Jean Giddens from Virginia Commonwealth University Appointed Chair of the AACN Board of Directors

Retrieved on: 
Monday, March 25, 2024

The American Association of Colleges of Nursing (AACN) is pleased to announce that Jean Giddens, PhD, RN, FAAN, ANEF, dean and professor of nursing at the Virginia Commonwealth University, has been appointed Chair of the AACN Board of Directors.

Key Points: 
  • The American Association of Colleges of Nursing (AACN) is pleased to announce that Jean Giddens, PhD, RN, FAAN, ANEF, dean and professor of nursing at the Virginia Commonwealth University, has been appointed Chair of the AACN Board of Directors.
  • Dr. Giddens officially began her two-year term as Board Chair at noon today following AACN’s Spring 2024 Business Meeting in Washington, DC.
  • Her distinguished career in nurse education encompasses leadership roles at the University of New Mexico, Mesa State College, University of Texas-El Paso, and Eastern New Mexico University.
  • In addition, AACN’s President and Chief Executive Officer Deborah Trautman serves as an ex-officio member of the AACN Board.

Northwell Health’s Feinstein Institutes for Medical Research establishes first Professor in Women’s Health Research, boosting national movement to close gender gaps

Retrieved on: 
Tuesday, March 19, 2024

Thanks to a generous endowment from women’s health advocates and philanthropists Iris and Saul Katz, Northwell Health and its home of medical research, the Feinstein Institutes for Medical Research , have established the Iris and Saul Katz Professor in Women’s Health Research in response to a national movement aimed at addressing the health care disparities facing women.

Key Points: 
  • Thanks to a generous endowment from women’s health advocates and philanthropists Iris and Saul Katz, Northwell Health and its home of medical research, the Feinstein Institutes for Medical Research , have established the Iris and Saul Katz Professor in Women’s Health Research in response to a national movement aimed at addressing the health care disparities facing women.
  • “While women’s health is now recognized as a national priority, Northwell has been addressing this issue for more than 15 years by creating solutions to close health gaps through the Katz Institute for Women’s Health , a network of more than 750 dedicated women’s health experts,” said Stacey E. Rosen, MD , executive director of the Katz Institute for Women’s Health, senior vice president of women’s health at Northwell and the Partners Council Professor of Women’s Health.
  • With more than 25 years of experience at North Shore University Hospital (NSUH) in Manhasset, she specializes in health equity, precision medicine and community-engaged research.
  • Cohn is highly regarded as a nurse-scientist and a champion for women’s health and medical research,” said Kevin J. Tracey, MD , president and CEO of the Feinstein Institutes and the Karches Family Distinguished Chair in Medical Research.

HD Nursing and WellnessMats Announce Strategic Partnership, Improving Comfort and Safety of Healthcare Professionals with Medical Grade Premium Standing Solutions

Retrieved on: 
Friday, March 15, 2024

“As the leader in Premium Standing Solutions and recognized for exemplary performance throughout various industries, we are thrilled to now join forces with HD Nursing and P4 to leverage our extensive experience to enhance the occupational comfort of medical and healthcare professionals,” says Daniel Bouzide, founder and president, WellnessMats. “This is a timely opportunity for healthcare leaders in virtually every healthcare setting to rethink and prioritize the well-being of their workforces and advance initiatives for employee retention -- one step at a time.”

Key Points: 
  • HD Nursing , the leading patient safety solution that combines predictive analytics with individualized fall and pressure injury prevention and WellnessMats , the leader in Premium Standing Solutions, proudly announce a strategic partnership.
  • This collaboration inaugurates a new era of improved comfort, safety, fatigue and stress relief for healthcare professionals and personnel throughout hospital and health system enterprises.
  • “This initiative underscores our joint dedication to advancing patient safety and supporting healthcare professionals throughout the healthcare ecosystem,” says Dr. Amy Hester, PhD, RN, BC, FAAN, chairwoman and CEO, HD Nursing.
  • Their professional-grade construction ensures a lasting investment that contributes to a positive work environment, improving employee retention and overall well-being.